Kudaibergen Osmonaliev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kudaibergen Osmonaliev has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Shafee Ur Rehman
Faculty of Medicine, Ala-Too International University, Bishkek, Kyrgyzstan
3 shared publications - K. Aknazarov
National surgical center
2 shared publications - Mirza Masroor Ali Beg
Faculty of Medicine Ala‐Too International University Bishkek Kyrgyzstan
2 shared publications - A. Habib
Ala-too International University, Kyrgyzstan
1 shared publication - A. Makambaev
National Surgery Center, Kyrgyzstan
1 shared publication - A. Shahzad
Ala-too International University, Kyrgyzstan
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e294105
Acute (destructive) pancreatitis: prediction of outcomes using artificial intelligence, a comprehensive review
Acute pancreatitis (AP) is a serious and potentially life-threatening condition characterized by a broad spectrum of disease severity, ranging from mild, self-limiting cases to severe, destructive forms associated with significant morbidity and mortality. Accurate prediction of clinical outcomes in AP is essential for timely intervention, effective resource allocation, and improved patient care. Recent advancements in artificial intelligence (AI) and machine learning (ML) have demonstrated significant potential in enhancing the accuracy of outcome prediction for acute pancreatitis. This article reviews the literature concerning the role of predictive models powered by artificial intelligence in acute pancreatitis (AP) focusing on their methods, evaluation criteria, and clinical usefulness. In addition, the review draws attention to data-related issues with the authors saying that the data is of insufficient quality, and the models cannot be properly explained, as well as other forms of bias in the algorithms used. Other ways are discussed, such as the use of real-time monitoring via wearable devices and the construction of explainable AI models, which shed light on the ways artificial intelligence is capable of changing the clinical approach to acute pancreatitis in the future.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e294105
Open AccessAcute (destructive) pancreatitis: prediction of outcomes using artificial intelligence, a comprehensive review
Acute pancreatitis (AP) is a serious and potentially life-threatening condition characterized by a broad spectrum of disease severity, ranging from mild, self-limiting cases to severe, destructive forms associated with significant morbidity and mortality. Accurate prediction of clinical outcomes in AP is essential for timely intervention, effective resource allocation, and improved patient care. Recent advancements in artificial intelligence (AI) and machine learning (ML) have demonstrated significant potential in enhancing the accuracy of outcome prediction for acute pancreatitis. This article reviews the literature concerning the role of predictive models powered by artificial intelligence in acute pancreatitis (AP) focusing on their methods, evaluation criteria, and clinical usefulness. In addition, the review draws attention to data-related issues with the authors saying that the data is of insufficient quality, and the models cannot be properly explained, as well as other forms of bias in the algorithms used. Other ways are discussed, such as the use of real-time monitoring via wearable devices and the construction of explainable AI models, which shed light on the ways artificial intelligence is capable of changing the clinical approach to acute pancreatitis in the future.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e292857
Exploring the role of genetic variants in oxidative stress susceptibility and disease risk
Oxidative stress, resulting from an imbalance between the production of reactive oxygen species (ROS) and the body's antioxidant defense mechanisms, is implicated in a wide range of physiological and pathological processes. Genetic factors play a significant role in determining an individual's susceptibility to oxidative stress and its associated disorders. This review explores the interplay between oxidative stress and genetics, highlighting the influence of genetic polymorphisms in key antioxidant enzymes and pathways such as superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), and the NRF2-KEAP1 signaling axis—on oxidative stress susceptibility. Additionally, the impact of oxidative stress-related genetic variants on the development and progression of various diseases, including neurodegenerative disorders, cardiovascular diseases, cancer, and metabolic syndromes, is discussed. Understanding the complex relationship between oxidative stress and genetics is essential for elucidating disease mechanisms, identifying potential biomarkers, and developing personalized therapeutic interventions targeting oxidative stress-related pathways.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e292857
Open AccessExploring the role of genetic variants in oxidative stress susceptibility and disease risk
Oxidative stress, resulting from an imbalance between the production of reactive oxygen species (ROS) and the body's antioxidant defense mechanisms, is implicated in a wide range of physiological and pathological processes. Genetic factors play a significant role in determining an individual's susceptibility to oxidative stress and its associated disorders. This review explores the interplay between oxidative stress and genetics, highlighting the influence of genetic polymorphisms in key antioxidant enzymes and pathways such as superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), and the NRF2-KEAP1 signaling axis—on oxidative stress susceptibility. Additionally, the impact of oxidative stress-related genetic variants on the development and progression of various diseases, including neurodegenerative disorders, cardiovascular diseases, cancer, and metabolic syndromes, is discussed. Understanding the complex relationship between oxidative stress and genetics is essential for elucidating disease mechanisms, identifying potential biomarkers, and developing personalized therapeutic interventions targeting oxidative stress-related pathways.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e292947
The development of predictive biomarkers and immunologic markers for breast cancer: current status and future perspectives
Breast cancer is the leading cause of cancer-related mortality among women worldwide. The development of predictive biomarkers and immunologic markers has revolutionized breast cancer diagnosis and treatment, enabling personalized medicine approaches. This study aims to review the current status, challenges, and future directions of predictive and immunologic biomarkers in breast cancer. Predictive biomarkers such as HER2/neu expression, estrogen receptor (ER)/progesterone receptor (PR) status, and genomic signatures play a crucial role in treatment decisions, particularly for hormone receptor-positive and HER2-positive tumors. Immunologic markers, including PD-L1 expression, microsatellite instability (MSI), tumor mutational burden (TMB), and tumor-infiltrating lymphocytes (TILs), are essential for predicting responses to immunotherapy, especially in aggressive subtypes like triple-negative breast cancer (TNBC). However, challenges such as tumor heterogeneity, therapy resistance, and standardization of biomarker testing remain significant barriers. This study also explores emerging technologies like artificial intelligence (AI), genomic profiling, and liquid biopsy, which are expected to enhance precision medicine, improve early diagnosis, and optimize treatment strategies. The integration of these advanced molecular approaches holds great promise for improving patient outcomes and overcoming existing limitations in breast cancer management.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e292947
Open AccessThe development of predictive biomarkers and immunologic markers for breast cancer: current status and future perspectives
Breast cancer is the leading cause of cancer-related mortality among women worldwide. The development of predictive biomarkers and immunologic markers has revolutionized breast cancer diagnosis and treatment, enabling personalized medicine approaches. This study aims to review the current status, challenges, and future directions of predictive and immunologic biomarkers in breast cancer. Predictive biomarkers such as HER2/neu expression, estrogen receptor (ER)/progesterone receptor (PR) status, and genomic signatures play a crucial role in treatment decisions, particularly for hormone receptor-positive and HER2-positive tumors. Immunologic markers, including PD-L1 expression, microsatellite instability (MSI), tumor mutational burden (TMB), and tumor-infiltrating lymphocytes (TILs), are essential for predicting responses to immunotherapy, especially in aggressive subtypes like triple-negative breast cancer (TNBC). However, challenges such as tumor heterogeneity, therapy resistance, and standardization of biomarker testing remain significant barriers. This study also explores emerging technologies like artificial intelligence (AI), genomic profiling, and liquid biopsy, which are expected to enhance precision medicine, improve early diagnosis, and optimize treatment strategies. The integration of these advanced molecular approaches holds great promise for improving patient outcomes and overcoming existing limitations in breast cancer management.
- 11 November 2024
- Published by Publishing Center Science and Practice in Bulletin of Science and Practice
- Vol. 10 (11) , 181-195
Hepatic Failure in Pancreonecrosis and the Development of Abdominal Sepsis
It is well known that acute destructive pancreatitis, pancreonecrosis is accompanied by severe endogenous intoxication, often leading to the development of multiple organ failure syndrome, liver failure is one of the important links in this process. The mortality rate of patients with pancreonecrosis related to liver failure is as high as 83%, and approximately 5% of patients with pancreonecrosis have fulminant liver failure. Proven: liver function is closely related to the progression of purulent-necrotic complications in patients with acute destructive pancreonecrosis. The authors present the data of literature on the importance of liver failure in the course and prognosis of acute destructive pancreatitis. The pathogenetic role of lipid peroxidation processes are especially emphasized. The controversial issues of portal and systemic bacteremia and toxemia in the development of pancreatogenic abdominal sepsis are discussed, as well as the involvement of the lymphatic system. The authors’ research aims to analytically dissect and summarize the processes underlying the clinical manifestations of liver failure in pancreatic necrosis and their underlying mechanisms, which may provide new insights for further understanding and better management of liver failure in patients with pancreatic necrosis and abdominal sepsis.
- 11 November 2024
- Published by Publishing Center Science and Practice in Bulletin of Science and Practice
- Vol. 10 (11) , 181-195
Hepatic Failure in Pancreonecrosis and the Development of Abdominal Sepsis
It is well known that acute destructive pancreatitis, pancreonecrosis is accompanied by severe endogenous intoxication, often leading to the development of multiple organ failure syndrome, liver failure is one of the important links in this process. The mortality rate of patients with pancreonecrosis related to liver failure is as high as 83%, and approximately 5% of patients with pancreonecrosis have fulminant liver failure. Proven: liver function is closely related to the progression of purulent-necrotic complications in patients with acute destructive pancreonecrosis. The authors present the data of literature on the importance of liver failure in the course and prognosis of acute destructive pancreatitis. The pathogenetic role of lipid peroxidation processes are especially emphasized. The controversial issues of portal and systemic bacteremia and toxemia in the development of pancreatogenic abdominal sepsis are discussed, as well as the involvement of the lymphatic system. The authors’ research aims to analytically dissect and summarize the processes underlying the clinical manifestations of liver failure in pancreatic necrosis and their underlying mechanisms, which may provide new insights for further understanding and better management of liver failure in patients with pancreatic necrosis and abdominal sepsis.
- 30 September 2021
- Published by Ala-Too International University in Alatoo Academic Studies
- Vol. 21 (3) , 370-382
DIAGNOSTIC ROLE OF EXOSOMES IN VARIOUS DISEASES
Exosomes are lipid bilayer- enclosed membrane bound extracellular vesicles (EVs) that secreted by cells under physiological conditions called extracellular vesicles (EV). EVs participate in are natural carrier which can transfer DNAs, RNAs, proteins, and lipids in autocrine, paracrine and endocrine manner. Exosome cargo having cell cycle related mRNA from cancer promotes proliferation of vascular endothelial cells and exosome play a significant role in angiogenesis by vascular endothelial cells. Exosome cargos showed significant role in pathogenesis of central nervous system related disease and exosomal content can act as biomarkers for specific central nervous system related disorders. It has been observed that viral infected cell release exosome more frequently as compared to non- infected cells; which might be act as indicator of viral infection. It was found that exosomes act as extracellular communicator in ischemic signaling and myocardial repair and several studies evidently prove that in adult heart, exosome secreted by myocardial tissue involved in hetero-cellular communication. It has been suggested that exosomes could play an important role in prognosis of various disease like cancer, disease related to nervous system, infections disease and cardiovascular disease. Exosomes secretion plays important role in disease pathogenesis and may be serve as an important biomedical tool as a biomarker in early detection of various disease.
- 30 September 2021
- Published by Ala-Too International University in Alatoo Academic Studies
- Vol. 21 (3) , 370-382
DIAGNOSTIC ROLE OF EXOSOMES IN VARIOUS DISEASES
Exosomes are lipid bilayer- enclosed membrane bound extracellular vesicles (EVs) that secreted by cells under physiological conditions called extracellular vesicles (EV). EVs participate in are natural carrier which can transfer DNAs, RNAs, proteins, and lipids in autocrine, paracrine and endocrine manner. Exosome cargo having cell cycle related mRNA from cancer promotes proliferation of vascular endothelial cells and exosome play a significant role in angiogenesis by vascular endothelial cells. Exosome cargos showed significant role in pathogenesis of central nervous system related disease and exosomal content can act as biomarkers for specific central nervous system related disorders. It has been observed that viral infected cell release exosome more frequently as compared to non- infected cells; which might be act as indicator of viral infection. It was found that exosomes act as extracellular communicator in ischemic signaling and myocardial repair and several studies evidently prove that in adult heart, exosome secreted by myocardial tissue involved in hetero-cellular communication. It has been suggested that exosomes could play an important role in prognosis of various disease like cancer, disease related to nervous system, infections disease and cardiovascular disease. Exosomes secretion plays important role in disease pathogenesis and may be serve as an important biomedical tool as a biomarker in early detection of various disease.